SIM
LXRX icon

Strategic Investment Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Strategic Investment Management’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-11,570
Closed -$138K – 107
2016
Q1 		$138K Buy
+11,570
New +$121K 0.07% 93

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Strategic Investment Management's LXRX Position: Q2 2016 in Review

Strategic Investment Management sold out of Lexicon Pharmaceuticals (LXRX) in Q2 2016, closing a stake of 11,570 shares — an estimated $138K sold.

Strategic Investment Management first reported a position in LXRX in Q1 2016 and held it in 1 quarter. The position peaked at $138K in Q1 2016. 137 funds tracked by Wall St. Rank hold LXRX as of Q2 2016.

  • Strategic Investment Management reported no remaining Lexicon Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • Strategic Investment Management sold 11,570 Lexicon Pharmaceuticals shares in Q2 2016, an estimated $138K.
  • Strategic Investment Management first reported a position in Lexicon Pharmaceuticals in Q1 2016 and held it in 1 quarter.
  • Strategic Investment Management's Lexicon Pharmaceuticals position peaked at $138K in Q1 2016.
  • 137 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2016.

Based on Strategic Investment Management's 13F filing for Q2 2016, filed 15 Aug 2016.